Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
Volume 0.52M
Average 1.46M
NNOX Income Before Tax
Profit after all operating and non-operating items but before income tax.
Nano-X Imaging Ltd.NASDAQ: NNOX
Income Before Tax · Q4 FY2025 · quarter ended Dec 2025
Income before tax remains negative
Q4 FY2025 income before tax was -$35.07M, compared with -$14.16M a year earlier. Trailing-twelve-month income before tax was -$76.81M.
Context
- Income before tax amounted to 589.9% of revenue in FY2025, up 112.4 pp from a year earlier.
- Income before tax grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly income before tax holds near -$35.07M or moves back toward the trailing-twelve-month quarterly average of -$19.2M.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Before Tax history
USD · from the income statement
- Latest · FY2025
- (76.81M) USD
- Year-over-year change
- -42.6%
| Period | Period end | Income Before Tax | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (76.81M) | -42.6% |
| FY2024 | 2024-12-31 | (53.87M) | +11.8% |
| FY2023 | 2023-12-31 | (61.12M) | +43.9% |
| FY2022 | 2022-12-31 | (108.92M) | -76.1% |
| FY2021 | 2021-12-31 | (61.85M) | — |
Income Before Tax vs competitors
How NNOX compares with its peers on the latest reported figures
- NNOX's LTM Dec 2025 income before tax of -$76.81M is the 7th highest of the 11 companies compared; the peer median is -$56.57M.
- Its year-over-year change of -42.6% is the 8th highest of 11, against a peer median of -1.5%.
- Income before tax amounts to 589.9% of revenue for NNOX, versus a peer median of 80.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $16.14M | +149.7% | — | 36.4% | |
| LTM Mar 2026 | -$25.61M | +8.6% | — | 7.3% | |
| LTM Mar 2026 | -$27.31M | -0.4% | — | 60.8% | |
| LTM Mar 2026 | -$38.96M | -2.6% | — | 206.5% | |
| LTM Mar 2026 | -$39.12M | +6.4% | — | 121.2% | |
| LTM Mar 2026 | -$74.03M | +34.7% | — | 63.0% | |
| LTM Dec 2025 | -$76.81M | -42.6% | — | 589.9% | |
| LTM Mar 2026 | -$106.4M | -110.6% | — | 73.4% | |
| LTM Mar 2026 | -$112.44M | -29.5% | — | 18194.2% | |
| LTM Mar 2026 | -$136.85M | -947.5% | — | 1427.1% | |
| LTM Mar 2026 | -$264.34M | -266.0% | — | 87.4% | |
| Peer median (excluding NNOX) | -$56.57M | -1.5% | — | 80.4% | |
Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.3M | 8.58M | 9.91M | 11.28M | 13.02M |
| Cost of Revenue | 2.82M | 15.46M | 16.5M | 21.89M | 25.81M |
| Gross Profit | (1.51M) | (6.88M) | (6.59M) | (10.61M) | (12.79M) |
| Gross Margin | -116.0% | -80.2% | -66.6% | -94.0% | -98.2% |
| Research & Development | 17.12M | 26.51M | 26.05M | 20.18M | 19.24M |
| Selling, General & Admin | 41.74M | 45.63M | 28.39M | 25.75M | 27.1M |
| Operating Expenses | 60.05M | 72.33M | 56M | 46.14M | 47.91M |
| Depreciation & Amortization | 2.29M | 11.51M | 11.81M | 11.73M | 11.7M |
| EBITDA | (59.27M) | (75.7M) | (47.69M) | (45.01M) | (49M) |
| EBITDA Margin | -4544.9% | -882.4% | -481.5% | -398.9% | -376.3% |
| Operating Income | (61.56M) | (109.71M) | (62.59M) | (56.75M) | (60.7M) |
| Operating Margin | -4720.7% | -1279.0% | -631.9% | -502.9% | -466.2% |
| Interest Income | 0 | 789K | 1.65M | 2.87M | 1.42M |
| Interest Expense | 288K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (288K) | (14.67M) | 1.47M | 2.87M | (16.11M) |
| Income Before Tax | (61.85M) | (108.92M) | (61.12M) | (53.87M) | (76.81M) |
| Pre-Tax Margin | -4742.8% | -1269.8% | -617.0% | -477.5% | -589.9% |
| Income Tax Expense | (48K) | (3.68M) | (339K) | (358K) | (1.79M) |
| Net Income | (61.8M) | (105.24M) | (60.78M) | (53.52M) | (75.02M) |
| Net Margin | -4739.1% | -1226.9% | -613.6% | -474.3% | -576.1% |
| EPS (Basic) | (1.28) | (2.01) | (1.08) | (0.91) | (1.16) |
| EPS (Diluted) | (1.28) | (2.01) | (1.08) | (0.91) | (1.16) |
| Weighted Avg Shares | 48.22M | 52.24M | 56.37M | 58.62M | 64.79M |
| Weighted Avg Shares (Diluted) | 48.22M | 52.24M | 56.37M | 58.62M | 64.79M |
Nano-X Imaging Ltd.
NASDAQ:NNOX
Intrinsic Alpha fair value
Locked
Current Price
$0.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.